0000950170-24-016193.txt : 20240216 0000950170-24-016193.hdr.sgml : 20240216 20240216112840 ACCESSION NUMBER: 0000950170-24-016193 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240213 FILED AS OF DATE: 20240216 DATE AS OF CHANGE: 20240216 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Howton David T CENTRAL INDEX KEY: 0001529297 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38360 FILM NUMBER: 24646301 MAIL ADDRESS: STREET 1: VERTEX PHARMACEUTICALS INCORPORATED STREET 2: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Solid Biosciences Inc. CENTRAL INDEX KEY: 0001707502 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 900943402 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 500 RUTHERFORD AVENUE STREET 2: 3RD FLOOR CITY: CHARLESTOWN STATE: MA ZIP: 02129 BUSINESS PHONE: 617-337-4680 MAIL ADDRESS: STREET 1: 500 RUTHERFORD AVENUE STREET 2: 3RD FLOOR CITY: CHARLESTOWN STATE: MA ZIP: 02129 FORMER COMPANY: FORMER CONFORMED NAME: Solid Biosciences, LLC DATE OF NAME CHANGE: 20170524 4 1 ownership.xml 4 X0508 4 2024-02-13 0001707502 Solid Biosciences Inc. SLDB 0001529297 Howton David T C/O SOLID BIOSCIENCES INC. 500 RUTHERFORD AVENUE, THIRD FLOOR CHARLESTOWN MA 02129 false true false false Chief Operating Officer false Employee Stock Option (Right to Buy) 7.85 2024-02-13 4 A false 117500 0 A 2034-02-13 Common Stock 117500 117500 D Restricted Stock Units 2024-02-13 4 A false 58750 0.00 A Common Stock 58750 58750 D This option was granted on February 13, 2024 (the "Grant Date") and vests over four years, with 25% of the original number of shares vesting on the first anniversary of the Grant Date and 2.0833% of the original number of shares monthly thereafter until the fourth such anniversary. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock (the "RSUs"). The RSUs were granted on the Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary. /s/ David Tyronne Howton 2024-02-16